Whitehawk Therapeutics, Inc. · NASDAQ:WHWK

Lennon David James sold 260,427 Whitehawk Therapeutics, Inc. shares (Form 4)

Traded Apr 6 to Apr 8, 2026 · Filed Apr 8, 2026

From Apr 6 to Apr 8, 2026, Lennon David James (Director, CHIEF EXECUTIVE OFFICER) sold 260,427 Whitehawk Therapeutics, Inc. shares at an average US$3.45 for US$900K, leaving 533,122 shares. Filed Apr 8, 2026 (Form 4).

Sold
260,427 shares
Price
US$3.45 average (US$3.40 to US$3.51)
Value
US$900K
Holding after
533,122 shares
Trading plan
No
Role
Director, CHIEF EXECUTIVE OFFICER

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 6, 2026Common StockSale102,395US$3.51691,154Direct
Apr 7, 2026Common StockSale94,087US$3.43597,067Direct
Apr 8, 2026Common StockSale63,945US$3.40533,122Direct

Source

View original at SEC

Related